Sellers Dorsey, a national healthcare impact strategy firm, has named Jennifer Duke as its new Chief Growth Officer, an important milestone in advancing the Firm’s mission to expand its reach and deepen its impact across the healthcare landscape.
With nearly 20 years of experience leading innovation, business growth, and strategic transformation, Duke brings a proven track record of aligning visionary strategies with measurable outcomes. Her expertise spans healthcare delivery, population health, managed care, AI-enabled digital health, and public-private partnerships. She has a proven track record of aligning bold commercial strategies with high-impact execution to drive value for clients.
Duke joins Sellers Dorsey from Oracle Health and Life Sciences, where she led global health network advisory services. In this role, she worked with providers, payers, and government agencies to deploy data-driven strategies that addressed complex regulatory requirements and population health challenges. Her work leveraged insights from clinical, financial, social, and environmental data to inform technology and services solutions that improved quality, patient experience, and cost of care.
“Jennifer’s leadership and expertise are a perfect fit for Sellers Dorsey,” said Kevin Seabaugh, CEO of Sellers Dorsey. “She understands how to move from data insights into scalable solutions, she acts with urgency, qualities that are essential for a healthcare impact firm like ours. We are confident she will help us grow our impact on the communities we support with our solutions and services.”
As Chief Growth Officer, Duke will oversee the Firm’s growth strategy and lead teams responsible for expanding Sellers Dorsey’s footprint across products, services, and markets. She will work closely with leaders across the Firm to align innovative offerings with client needs and ensure measurable outcomes for the communities our clients serve.
“I’m excited to join Sellers Dorsey and contribute to its mission of improving healthcare, quality, access, and outcomes,” said Duke. “The Firm’s deep expertise, combined with its commitment to impact, makes it a powerful force for positive change in healthcare. I look forward to helping bring more solutions to more clients and advancing the health of the populations we serve.”
Prior to her role at Oracle, Duke held senior roles in business development and strategic growth, where she led the acquisition and expansion of healthcare assets and virtual care models designed to improve affordability and access, especially for underserved populations. She began her career at Cardinal Health and Johnson & Johnson, helping clinical teams adopt breakthrough medical technologies to advance the Quadruple Aim, a framework that outlines four key objectives for improving healthcare delivery: improve patient experience, improve population health, reduce costs, and improve provider well-being.
Duke holds a Bachelor of Science in Business Management from Baker University. Her appointment marks a pivotal chapter for Sellers Dorsey as it accelerates its mission to support health systems, Medicaid programs, and the vulnerable populations they serve.
